Profilo
Cora Holland Haffner is currently the Director of Operations at Chartline Capital Management LLC.
She has a graduate degree from Chestnut Hill College, which she received in 2000, and an undergraduate degree from West Virginia Wesleyan College, which she received in 1994.
Posizioni attive di Cora Haffner
| Società | Posizione | Inizio |
|---|---|---|
Chartline Capital Management LLC
Chartline Capital Management LLC Investment ManagersFinance Chartline Capital seeks investment opportunities in companies located in the United States with an annual revenue of USD 2 - 7 million. The firm focuses on companies operating in HR tech, fintech, digital industrials and proptech and real estate sectors. It does not invest in seed or pre-seed, pre-IPO secondaries, beltway growth rounds and sectors such as B2C, crypto, material science therapeutics. It provides financing for early-stage capital requirements with transaction sizes of USD 0.50 - USD 5 million. | Investitore di Private Equity | - |
Formazione di Cora Haffner
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 3 |
|---|---|
Chestnut Hill College
Chestnut Hill College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
West Virginia Wesleyan College
West Virginia Wesleyan College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Chartline Capital Management LLC
Chartline Capital Management LLC Investment ManagersFinance Chartline Capital seeks investment opportunities in companies located in the United States with an annual revenue of USD 2 - 7 million. The firm focuses on companies operating in HR tech, fintech, digital industrials and proptech and real estate sectors. It does not invest in seed or pre-seed, pre-IPO secondaries, beltway growth rounds and sectors such as B2C, crypto, material science therapeutics. It provides financing for early-stage capital requirements with transaction sizes of USD 0.50 - USD 5 million. | Finance |
















